NCT00501072
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +7 more
- Locations
-
- Diabetes Outpatient Clinic, Isala clinics Zwolle, Netherlands
Clinical trial condition
Diabetes Mellitus, Type 1
Explore clinical trials studying Diabetes Mellitus, Type 1. Study availability and eligibility vary by location and protocol.
887 public trials
62 recruiting studies
Diabetes Mellitus, Type 1 trial results
NCT00286962
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
- Locations
-
- Isala Klinieken Zwolle, Netherlands
NCT00143104
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
- Locations
-
- Pfizer Investigational Site Glendale, Arizona, United States
- Pfizer Investigational Site Fresno, California, United States
- Pfizer Investigational Site San Antonio, Texas, United States
NCT00623610
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
- Locations
-
- Universitair Ziekenhuis and Diabetes Research Center - Brussels Free University-VUB Brussels, Belgium
- Department of Endocrinology and Nephrology, UZ Gasthuisberg, Katholieke Universiteit Leuven -KUL Leuven, Belgium
NCT00595569
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +7 more
- Locations
-
- University of Basel Hospital Basel, Switzerland
Completed
Safety and Efficacy of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus.
NCT00063128
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Diego, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Denver, Colorado, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hollywood, Florida, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New Port Richey, Florida, United States
NCT00374270
- Conditions
- Autoimmune Diseases, Cardiovascular Diseases, Diabetes Mellitus, +9 more
- Locations
-
- University of Alberta Edmonton, Alberta, Canada
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
- Locations
-
Not specified
NCT00462371
- Conditions
- Autoimmune Diseases, Child, Diabetes Mellitus, +6 more
- Locations
-
- ErasmusMC/Sophia´s children´s Hospital Rotterdam, Netherlands
NCT00424437
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
- Locations
-
- Pfizer Investigational Site Burlingame, California, United States
- Pfizer Investigational Site Irvine, California, United States
- Pfizer Investigational Site Newport Beach, California, United States
- Pfizer Investigational Site San Diego, California, United States